KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilent Technologies (A) Cash & Equivalents (2016 - 2026)

Agilent Technologies has reported Cash & Equivalents over the past 18 years, most recently at $1.8 billion for Q1 2026.

  • Quarterly Cash & Equivalents rose 19.84% to $1.8 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.8 billion through Jan 2026, up 19.84% year-over-year, with the annual reading at $1.8 billion for FY2025, 34.61% up from the prior year.
  • Cash & Equivalents was $1.8 billion for Q1 2026 at Agilent Technologies, down from $1.8 billion in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $1.8 billion in Q4 2025 and troughed at $1.1 billion in Q4 2022.
  • The 5-year median for Cash & Equivalents is $1.5 billion (2025), against an average of $1.4 billion.
  • Year-over-year, Cash & Equivalents decreased 29.04% in 2022 and then skyrocketed 51.0% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $1.1 billion in 2022, then surged by 51.0% to $1.6 billion in 2023, then dropped by 16.42% to $1.3 billion in 2024, then skyrocketed by 34.61% to $1.8 billion in 2025, then dropped by 1.73% to $1.8 billion in 2026.
  • Per Business Quant, the three most recent readings for A's Cash & Equivalents are $1.8 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.5 billion (Q3 2025).